• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未足月胎膜早破:ACOG 实践简报摘要,第 217 号。

Prelabor Rupture of Membranes: ACOG Practice Bulletin Summary, Number 217.

出版信息

Obstet Gynecol. 2020 Mar;135(3):739-743. doi: 10.1097/AOG.0000000000003701.

DOI:10.1097/AOG.0000000000003701
PMID:32080044
Abstract

Preterm birth occurs in approximately 10% of all births in the United States and is a major contributor to perinatal morbidity and mortality (). Prelabor rupture of membranes (PROM) that occurs preterm complicates approximately 2-3% of all pregnancies in the United States, representing a significant proportion of preterm births, whereas term PROM occurs in approximately 8% of pregnancies (). The optimal approach to assessment and treatment of women with term and preterm PROM remains challenging. Management decisions depend on gestational age and evaluation of the relative risks of delivery versus the risks (eg, infection, abruptio placentae, and umbilical cord accident) of expectant management when pregnancy is allowed to progress to a later gestational age. The purpose of this document is to review the current understanding of this condition and to provide management guidelines that have been validated by appropriately conducted outcome-based research when available. Additional guidelines on the basis of consensus and expert opinion also are presented. This Practice Bulletin is updated to include information about diagnosis of PROM, expectant management of PROM at term, and timing of delivery for patients with preterm PROM between 34 0/7 weeks of gestation and 36 6/7 weeks of gestation.

摘要

早产在美国约占所有分娩的 10%,是围产期发病率和死亡率的主要原因()。早产时发生的胎膜早破(PROM)约占美国所有妊娠的 2-3%,占早产的很大比例,而足月时发生的 PROM 约占妊娠的 8%()。对于足月和早产 PROM 的妇女,评估和治疗的最佳方法仍然具有挑战性。管理决策取决于胎龄,并评估分娩的相对风险与允许妊娠进展到较晚胎龄时的风险(例如感染、胎盘早剥和脐带意外)。本文件的目的是回顾对这种情况的现有认识,并提供管理指南,这些指南在有条件进行基于结果的研究时已得到验证。此外,还根据共识和专家意见提出了其他指南。本实践公告已更新,包括关于 PROM 诊断、足月 PROM 的期待治疗以及 34 0/7 周至 36 6/7 周之间的早产 PROM 患者分娩时机的信息。

相似文献

1
Prelabor Rupture of Membranes: ACOG Practice Bulletin Summary, Number 217.未足月胎膜早破:ACOG 实践简报摘要,第 217 号。
Obstet Gynecol. 2020 Mar;135(3):739-743. doi: 10.1097/AOG.0000000000003701.
2
Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217.胎膜早破:ACOG 实践公告第 217 号。
Obstet Gynecol. 2020 Mar;135(3):e80-e97. doi: 10.1097/AOG.0000000000003700.
3
ACOG Practice Bulletin No. 188 Summary: Prelabor Rupture of Membranes.美国妇产科医师学会实践公告第188号摘要:胎膜早破
Obstet Gynecol. 2018 Jan;131(1):187-189. doi: 10.1097/AOG.0000000000002449.
4
ACOG Practice Bulletin No. 188: Prelabor Rupture of Membranes.美国妇产科医师学会实践公告第188号:胎膜早破
Obstet Gynecol. 2018 Jan;131(1):e1-e14. doi: 10.1097/AOG.0000000000002455.
5
Practice Bulletin No. 172 Summary: Premature Rupture of Membranes.第172号实践公告摘要:胎膜早破
Obstet Gynecol. 2016 Oct;128(4):934-936. doi: 10.1097/AOG.0000000000001703.
6
Practice Bulletin No. 172: Premature Rupture of Membranes.第172号实践公告:胎膜早破
Obstet Gynecol. 2016 Oct;128(4):e165-77. doi: 10.1097/AOG.0000000000001712.
7
Practice Bulletin No. 160 Summary: Premature Rupture of Membranes.实践公告第 160 号摘要:胎膜早破。
Obstet Gynecol. 2016 Jan;127(1):192-194. doi: 10.1097/AOG.0000000000001261.
8
Practice bulletins No. 139: premature rupture of membranes.实践通报第 139 号:胎膜早破。
Obstet Gynecol. 2013 Oct;122(4):918-930. doi: 10.1097/01.AOG.0000435415.21944.8f.
9
Practice Bulletin No. 160: Premature Rupture of Membranes.实践通报第 160 号:胎膜早破。
Obstet Gynecol. 2016 Jan;127(1):e39-e51. doi: 10.1097/AOG.0000000000001266.
10
ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists.美国妇产科医师学会实践公告第80号:胎膜早破。妇产科医生临床管理指南
Obstet Gynecol. 2007 Apr;109(4):1007-19. doi: 10.1097/01.AOG.0000263888.69178.1f.

引用本文的文献

1
Prognostic evaluation of albumin-associated inflammatory indices (LAR, NAR, MAR, FAR, SII/Alb, SIRI/Alb, NPAR, and CAR) in preterm premature rupture of membranes (PPROM) pregnancies.胎膜早破(PPROM)妊娠中白蛋白相关炎症指标(LAR、NAR、MAR、FAR、SII/Alb、SIRI/Alb、NPAR和CAR)的预后评估
BMC Pregnancy Childbirth. 2025 Jul 12;25(1):759. doi: 10.1186/s12884-025-07877-6.
2
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of Membranes.早产的预防与治疗。德国妇产科学会、奥地利妇产科学会和瑞士妇产科学会指南(S2k级别,德国医学质量与效率理事会注册编号015/025,2022年9月)——第2部分:早产三级预防及胎膜早破管理的建议
Geburtshilfe Frauenheilkd. 2023 May 4;83(5):569-601. doi: 10.1055/a-2044-0345. eCollection 2023 May.
3
Maternal morbidity under an absolute abortion ban: insights from a 6-year case series of fatal fetal malformations in El Salvador.绝对堕胎禁令下的孕产妇发病率:来自萨尔瓦多6年致命胎儿畸形病例系列的见解。
AJOG Glob Rep. 2022 Dec 17;3(1):100147. doi: 10.1016/j.xagr.2022.100147. eCollection 2023 Feb.
4
Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis.抗生素预防胎膜早破孕妇感染:系统评价和荟萃分析。
Einstein (Sao Paulo). 2022 Dec 2;20:eRW0015. doi: 10.31744/einstein_journal/2022RW0015. eCollection 2022.
5
Expectant management of preterm premature rupture of membranes at 34 weeks: a cost effectiveness analysis.期待治疗 34 周时的早产胎膜早破:成本效益分析。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):9136-9144. doi: 10.1080/14767058.2021.2017874. Epub 2021 Dec 16.
6
Antenatal dexamethasone use and respiratory distress in late preterm infants: results from first Vietnamese matched cohort study.产前使用地塞米松与晚期早产儿呼吸窘迫:来自越南首个匹配队列研究的结果。
BMC Pregnancy Childbirth. 2021 Aug 7;21(1):546. doi: 10.1186/s12884-021-04019-6.
7
Obstetric and Perinatal Outcomes after Very Early Preterm Premature Rupture of Membranes (PPROM)-A Retrospective Analysis over the Period 2000-2020.极早早产胎膜早破(PPROM)的产科和围产期结局 - 2000 年至 2020 年期间的回顾性分析。
Medicina (Kaunas). 2021 May 11;57(5):469. doi: 10.3390/medicina57050469.